-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Author: Fang original
On March 5th, the Medical Insurance Bureau and the Department of Recruitment and Procurement and representatives from 11 provinces and cities including Tianjin, Shanghai, Chongqing and other joint procurement offices organized a drug centralized procurement work conference in Nanjing.
According to the news received late at night last night, Nanjing’s main topics are four:
The country will carry out special procurement with quantities, and the first batch of test water varieties will be insulin.
For the 4+7 contract renewal issue, the state will delegate power to local governments and point out the overall guiding principles.
Essence drugs will be included in the national procurement, but category 1 will not be included, and the inclusion of category 2 psychotropic drugs may be fully liberalized.
The meeting summarized the collection of two diseased varieties in Shanxi and the Beijing-Tianjin-Hebei Alliance and the first batch of collections in six provinces and two districts.
The amount of information is large.
The amount of information is large.
1.
The Nanjing meeting clarified the special procurement of insulin.
2.
2.
3.
3.
The key point is that the 500 varieties circulated in 2020 are believed to be only a relatively solid range of the corresponding time period.
After the issuance of Circular 2, this year, the national level will focus on optimizing the volume procurement rules and try to create a model pilot, while the local level has fully implemented the volume procurement work.
